Sign in

CIK 0001842952

  • Emerging growth company

Context Therapeutics Inc.

Sign in to watch
Ticker
CNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
863738787
Phone
+1 267-225-7416
Business address
2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
Former names
Context Therapeutics LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-19 Levit Alex C. Chief Legal Officer, Corp. Sec Grant or award · Stock Option (right to buy) +270,000 270,000
2025-06-06 Levit Alex C. Chief Legal Officer, Corp. Sec Purchase +20,000 $0.58 $12K 29,000
2025-02-13 Levit Alex C. Chief Legal Officer, Corp. Sec Grant or award · Stock Option (right to buy) +349,900 349,900
2024-03-21 Levit Alex C. Chief Legal Officer, Corp. Sec Grant or award · Stock Option (right to buy) +153,515 153,515
2023-02-13 Levit Alex C. Chief Legal Officer, Corp. Sec Grant or award · Stock Option (right to buy) +151,505 151,505
2022-12-09 Levit Alex C. Chief Legal Officer, Corp. Sec Purchase +6,000 $0.85 $5K 9,000
2022-02-25 Levit Alex C. Chief Legal Officer, Corp. Sec Grant or award · Stock Option (right to buy) +107,870 107,870
2021-10-22 Levit Alex C. Chief Legal Officer, Corp. Sec Purchase +3,000 $5.00 $15K 3,000

Page 1 of 1 · 8 trades